Search Result "type I MET-TKI"
The Treatment of a New Entity in Advanced Non-small Cell LungCancer: MET Exon 14 Skipping Mutation
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 21 Year: 2024 Page: 3043-3056
Author(s): Luigi Della Gravara
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1263-1272
Author(s): Shigehiro Yagishita,Akinobu Hamada
The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 37 Year: 2012 Page: 6155-6168
Author(s): Assunta Sgambato,Francesca Casaluce,Paolo Maione,Antonio Rossi,Emanuela Rossi,Alba Napolitano,Giovanni Palazzolo,Maria Anna Bareschino,Clorinda Schettino,Paola Claudia Sacco,Fortunato Ciardiello,Cesare Gridelli
Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 851-864
Author(s): A. De Luca, N. Normanno
HGF/c-MET: A Potential Target for the Treatment of Various Cancers
Journal: Current Enzyme Inhibition
Volume: 19 Issue: 2 Year: 2023 Page: 71-80
Author(s): Dinesh Kumar Chellappan,Sachin Kumar Singh,Sabapathi Mohana Lakshmi
Mechanisms of Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-Small-Cell Lung Cancer: Clinical and Molecular Considerations
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1613-1628
Author(s): A. Pallis, E. Briasoulis, H. Linardou, C. Papadimitriou, D. Bafaloukos, P. Kosmidis, S. Murray
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 12 Issue: 6 Year: 2011 Page: 922-933
Author(s): Laura Bonanno, Antonio Jirillo, Adolfo Favaretto
High Throughput Study for Molecular Mechanism of MetforminPre-Diabetic Protection via Microarray Approach
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 1 Year: 2022 Page: 71-99
Author(s): Asma Y. Alrawashdeh,Mohammad A. AL Shhab,Malek A. Zihlif
Synthesis, In Silico Prediction, and In Vitro Evaluation of Anti-tumorActivities of Novel 4'-Hydroxybiphenyl-4-carboxylic Acid Derivativesas EGFR Allosteric Site Inhibitors
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 38 Year: 2024 Page: 6336-6356
Author(s): Wurood A. Shihab,Ammar A. Razzak Kubba,Lubna H. Tahtamouni,Khaled M. Saleh,Mai F. AlSakhen,Sana I. Kanaan,Abdulrahman M. Saleh,Salem R. Yasin
Tumor Resistance Mechanisms to Inhibitors Targeting the Epidermal Growth Factor Receptorâ Part I: Extracellular Molecules
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 3 Year: 2016
Author(s): Rodney B. Luwor